Novartis signs agreement to acquire Anthos for $925m upfront
The acquisition aligns with Novartis’ growth strategy and therapeutic area focus. Credit: © 2025 Novartis AG. Novartis has agreed to acquire Boston-based clinical-stage biopharmaceutical company